ResMed (RMD) Peer Comparison
$240.10
$-0.23
(-0.10%)
As on 31-Aug-2026 16:29EDT
Market cap
$32,953 Mln
Revenue (TTM)
$5,653 Mln
P/E Ratio
22.1
P/B Ratio
5.1
Div. Yield
1 %
Edit
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
32,953 | 232,035 | 201,832 | 151,782 | 133,494 |
Revenue ($ Mln) |
5,653 | 46,336 | 46,585 | 25,107 | 11,034 |
Net Profit ($ Mln) |
1,523.29 | 6,978.00 | 5,425.00 | 4,004.00 | 3,138.80 |
Net Margin (%) |
26.94 | 15.06 | 11.65 | 15.95 | 28.45 |
RoE (%) |
24.27 | 13.12 | 10.51 | 7.62 | 17.34 |
Price to Earnings |
22.11 | 33.01 | 36.91 | 37.75 | 42.63 |
Price-To-Book |
5.05 | 4.31 | 3.86 | 2.83 | 7.14 |
Income Statement ($ Mln)
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
5,653.44 | -- | -- | -- | -- |
|
Cost of Revenue
|
2,195.77 | -- | -- | -- | -- |
|
Gross Profit
|
3,457.68 | -- | -- | -- | -- |
|
Operating Expenses
|
1,565.03 | -- | -- | -- | -- |
|
Operating Profit (EBIT)
|
1,892.65 | -- | -- | -- | -- |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
1,919.42 | -- | -- | -- | -- |
|
Provision for Tax
|
396.12 | -- | -- | -- | -- |
|
Profit after Tax (Net Income)
|
1,523.29 | -- | -- | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,585.39 | -- | -- | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
985.45 | -- | -- | -- | -- |
|
Current Liabilities
|
1,395.11 | -- | -- | -- | -- |
|
Total Liabilities
|
8,965.95 | -- | -- | -- | -- |
Assets ($ Mln)
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
4,641.21 | -- | -- | -- | -- |
|
Current Assets
|
4,324.74 | -- | -- | -- | -- |
|
Total Assets
|
8,965.95 | -- | -- | -- | -- |
|
Total Debt*
|
825.92 | -- | -- | -- | -- |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,805.83 | -- | -- | -- | -- |
|
Cash Flow from Investing Activities
|
-545.20 | -- | -- | -- | -- |
|
Cash from Financing Activities
|
-1,007.03 | -- | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
21.41 | -- | -- | -- | -- |
|
ROE (%)
|
24.27 | -- | -- | -- | -- |
|
ROA (%)
|
17.77 | -- | -- | -- | -- |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
26.94 | -- | -- | -- | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.10 | -- | -- | -- | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
8.75 | -- | -- | -- | -- |
|
EPS Growth (%)
|
0.10 | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
18.55 | -- | -- | -- | -- |
|
Price / Book Value
|
4.29 | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
12.86 | -- | -- | -- | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.13 | -- | -- | -- | -- |
|
Short term debt to equity ratio
|
0.04 | -- | -- | -- | -- |
|
Current Ratio
|
3.10 | -- | -- | -- | -- |
|
Quick Ratio
|
2.42 | -- | -- | -- | -- |
|
Interest Coverage
|
67.12 | -- | -- | -- | -- |
Operating Efficiency Ratios
| ResMed (RMD) | Thermo Fisher Scientific (TMO) | Abbott Laboratories (ABT) | Danaher (DHR) | Intuitive Surgical (ISRG) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.33 | -- | -- | -- | -- |
|
Asset Turnover
|
0.66 | -- | -- | -- | -- |
|
Receivable days
|
65.48 | -- | -- | -- | -- |
|
Inventory Days
|
155.82 | -- | -- | -- | -- |
|
Payable days
|
48.83 | -- | -- | -- | -- |
|
Cash Conversion Cycle
|
172.47 | -- | -- | -- | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
